This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing new treatments for FA with members of the Friedreich's Ataxia Research Alliance (FARA)

Ticker(s): RETA

Who's the expert?

Institution: Friedreich's Ataxia Research Alliance

  • Chief Executive Officer of the Friedreich's Ataxia Research Alliance. 
  • Previously worked as a genetic counselor at CHOP developing a special interest in neurogenetic conditions; shewent on to establish and coordinate clinical and research programs for individuals and families diagnosed with Friedreich Ataxia (FA) and other neurodegenerative diseases. 
  • Led FARA's efforts to establish clinical research infrastructure and clinical trial readiness, grown the research grant program from funding <1M annually to >6M annually, led efforts to engage bio-pharma industry in FA drug discovery and development, and ensured highly efficient and transparent organizational growth and development. 

Interview Goal
This conversation will focus on the FA pipeline with a member of FARA.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.